Boris Afonso Cruz
Mini Conferência: Uso de Biológicos nas Vasculites - a Ferreira; Moderador: Vanja Diniz Rabelo Caires
| Artigo | Autor(es) | Referência |
|---|---|---|
| Anti-Glomerular Basement Membrane Disease. | Gulati Kavita, McAdoo Stephen P | Rheumatic diseases clinics of North America. 2018 11; 44(11):651-673. doi: 10.1016/j.rdc.2018.06.011. pii: S0889-857X(18)30064-4. |
| Apheresis to treat systemic vasculitis. | Moussi-Frances Julie, Sallée Marion, Jourde-Chiche Noémie | Joint bone spine. 2018 03; 85(03):177-183. doi: 10.1016/j.jbspin.2017.06.001. pii: S1297-319X(17)30117-3. |
| Biologics for childhood systemic vasculitis. | Akamine Keiji, Punaro Marilynn | Pediatric nephrology (Berlin, Germany). 2019 11; 34(11):2295-2309. doi: 10.1007/s00467-018-4076-2. pii: . |
| Conventional and biological immunosuppressants in vasculitis. | Guillevin Loic, Mukhtyar Chetan, Pagnoux Christian, Yates Max | Best practice & research. Clinical rheumatology. 2018 02; 32(02):94-111. doi: 10.1016/j.berh.2018.07.006. pii: S1521-6942(18)30031-7. |
| Current advances in the treatment of giant cell arteritis: the role of biologics. | Low Candice, Conway Richard | Therapeutic advances in musculoskeletal disease. 2019 ; 11():1759720X19827222. doi: 10.1177/1759720X19827222. pii: . |
| Current perspective on rituximab in rheumatic diseases. | Schioppo Tommaso, Ingegnoli Francesca | Drug design, development and therapy. 2017 ; 11():2891-2904. doi: 10.2147/DDDT.S139248. pii: . |
| Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). | Nakaoka Yoshikazu, Isobe Mitsuaki, Takei Syuji, Tanaka Yoshiya, Ishii Tomonori, Yokota Shumpei, Nomura Akira, Yoshida Seitaro, Nishimoto Norihiro | Annals of the rheumatic diseases. 2018 03; 77(03):348-354. doi: 10.1136/annrheumdis-2017-211878. pii: . |
| Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies. | Fabiani Claudia, Sota Jurgen, Rigante Donato, Vitale Antonio, Emmi Giacomo, Lopalco Giuseppe, Vannozzi Lorenzo, Guerriero Silvana, Bitossi Alice, Orlando Ida, Franceschini Rossella, Frediani Bruno, Galeazzi Mauro, Iannone Florenzo, Tosi Gian Marco, Cantarini Luca | Clinical rheumatology. 2018 Oct; 37(Oct):2805-2809. doi: 10.1007/s10067-018-4133-z. pii: . |
| Goodpasture's syndrome: a clinical update. | Greco Antonio, Rizzo Maria Ida, De Virgilio Armando, Gallo Andrea, Fusconi Massimo, Pagliuca Giulio, Martellucci Salvatore, Turchetta Rosaria, Longo Lucia, De Vincentiis Marco | Autoimmunity reviews. 2015 Mar; 14(Mar):246-53. doi: 10.1016/j.autrev.2014.11.006. pii: S1568-9972(14)00278-X. |
| Pulmonary-renal syndrome: a life threatening but treatable condition. | West Stephen C, Arulkumaran Nishkantha, Ind Philip W, Pusey Charles D | Postgraduate medical journal. 2013 May; 89(May):274-83. doi: 10.1136/postgradmedj-2012-131416. pii: . |
| Trial of Tocilizumab in Giant-Cell Arteritis. | Stone John H, Tuckwell Katie, Dimonaco Sophie, Klearman Micki, Aringer Martin, Blockmans Daniel, Brouwer Elisabeth, Cid Maria C, Dasgupta Bhaskar, Rech Juergen, Salvarani Carlo, Schett Georg, Schulze-Koops Hendrik, Spiera Robert, Unizony Sebastian H, Collinson Neil | The New England journal of medicine. 2017 07; 377(07):317-328. doi: 10.1056/NEJMoa1613849. pii: . |
| [Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]. | Proft F, Schulze-Koops H, Grunke M, Schrezenmeier E, Halleck F, Henes J, Unger L, Schmidt E, Fiehn C, Jacobi A, Iking-Konert C, Kneitz C, Schmidt R E, Bannert B, Voll R E, Fischer-Betz R, Kötter I, Tony H P, Holle J, Aringer M, Erler A, Behrens F, Burmester G R, Dörner T | Zeitschrift fur Rheumatologie. 2018 Feb; 77(Feb):28-39. doi: 10.1007/s00393-017-0330-4. pii: . |
| [The pulmonary-renal syndrome: a diagnostic and therapeutic emergency for the internist and the intensivist]. | Hié M, Costedoat-Chalumeau N, Saadoun D, Azoulay E | La Revue de medecine interne. 2013 Nov; 34(Nov):679-86. doi: 10.1016/j.revmed.2013.02.003. pii: S0248-8663(13)00048-9. |